oa Southern African Journal of Gynaecological Oncology - Modelling research shows Cervarix-induced immune response may be prolonged for at least 20 years for both HPV 16 and 18 : press release
|Article Title||Modelling research shows Cervarix-induced immune response may be prolonged for at least 20 years for both HPV 16 and 18 : press release|
|© Publisher:||Medpharm Publications|
|Journal||Southern African Journal of Gynaecological Oncology|
|Publication Date||Jan 2009|
Results of three statistical models presented recently at the European Research Organisation on Genital Infection and Neoplasia (EUROGIN) annual meeting in Nice suggest that young women vaccinated with GlaxoSmithKline's HPV vaccine Cervarix could look forward to a prolonged immune response against the two most common cancer-causing human papillomavirus virus (HPV), types HPV 16 and 18 for at least 20 years.
Article metrics loading...